KOST, MOTION OG DNA ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  25.2% 22.7% 16.1% 23.5% 15.2%  
Credit score (0-100)  4 4 10 3 12  
Credit rating  B B BB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  30 0 0 0 0  
Gross profit  15.5 -21.1 0.0 0.7 -45.5  
EBITDA  96.4 -63.9 -43.0 -4.9 -45.5  
EBIT  96.4 -63.9 -43.0 -4.9 -45.5  
Pre-tax profit (PTP)  96.4 -63.9 -43.0 -5.5 -45.5  
Net earnings  96.4 -63.9 -43.0 -5.5 -45.5  
Pre-tax profit without non-rec. items  96.4 -63.9 -43.0 -5.5 -45.5  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  64.3 64.3 64.3 195 -45.5  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 34.7  
Balance sheet total (assets)  64.3 64.3 64.3 195 4.1  

Net Debt  0.0 0.0 0.0 -57.6 34.7  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  30 0 0 0 0  
Net sales growth  -68.4% -100.0% 0.0% 0.0% 0.0%  
Gross profit  15.5 -21.1 0.0 0.7 -45.5  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  -81.0 -42.8 -43.0 -0.3 0.0  
Balance sheet total (assets)  64 64 64 195 4  
Balance sheet change%  -13.5% 0.0% 0.0% 203.6% -97.9%  
Added value  177.4 -21.1 0.0 -4.7 -45.5  
Added value %  593.3% 0.0% 0.0% 0.0% 0.0%  
Investments  -10 0 0 0 0  

Net sales trend  -2.0 -3.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  322.5% 0.0% 0.0% 0.0% 0.0%  
EBIT %  322.5% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  623.6% 303.1% 0.0% -694.1% 100.0%  
Net Earnings %  322.5% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  322.5% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  322.5% 0.0% 0.0% 0.0% 0.0%  
ROA %  139.1% -99.4% -66.9% -3.8% -37.2%  
ROI %  139.1% -99.4% -66.9% -3.8% -39.6%  
ROE %  139.1% -99.4% -66.9% -4.2% -45.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  100.0% 100.0% 100.0% 100.0% -91.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 1,165.9% -76.2%  
Gearing %  0.0% 0.0% 0.0% 0.0% -76.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.0 0.3  
Current Ratio  0.0 0.0 0.0 0.0 0.3  
Cash and cash equivalent  0.0 0.0 0.0 57.6 0.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  785.2 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  215.1% 0.0% 0.0% 0.0% 0.0%  
Net working capital  64.3 64.3 64.3 195.3 -10.8  
Net working capital %  215.1% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0